UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:CD22-CADPS |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: CD22-CADPS | FusionPDB ID: 14412 | FusionGDB2.0 ID: 14412 | Hgene | Tgene | Gene symbol | CD22 | CADPS | Gene ID | 933 | 8618 |
Gene name | CD22 molecule | calcium dependent secretion activator | |
Synonyms | SIGLEC-2|SIGLEC2 | CADPS1|CAPS|CAPS1|UNC-31 | |
Cytomap | 19q13.12 | 3p14.2 | |
Type of gene | protein-coding | protein-coding | |
Description | B-cell receptor CD22B-lymphocyte cell adhesion moleculeBL-CAMCD22 antigenT-cell surface antigen Leu-14sialic acid-binding Ig-like lectin 2 | calcium-dependent secretion activator 1CAPS-1Ca++-dependent secretion activatorCa2+ dependent secretion activatorCa2+-dependent activator protein for secretionCa2+-regulated cytoskeletal proteincalcium-dependent activator protein for secretion 1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q15762 | Q86UW7 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000595419, ENST00000085219, ENST00000270311, ENST00000341773, ENST00000419549, ENST00000536635, ENST00000544992, ENST00000594250, | ENST00000283269, ENST00000357948, ENST00000383710, ENST00000490353, ENST00000462768, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 3 X 2 X 2=12 | 6 X 5 X 5=150 |
# samples | 4 | 7 | |
** MAII score | log2(4/12*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/150*10)=-1.09953567355091 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: CD22 [Title/Abstract] AND CADPS [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CD22(35820133)-CADPS(62751659), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | CD22-CADPS seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CD22-CADPS seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CD22-CADPS seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CD22-CADPS seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CD22-CADPS seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CD22 | GO:0030100 | regulation of endocytosis | 17562860 |
Hgene | CD22 | GO:0042113 | B cell activation | 26017478 |
Hgene | CD22 | GO:0050859 | negative regulation of B cell receptor signaling pathway | 26017478 |
Fusion gene breakpoints across CD22 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CADPS (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | OV | TCGA-25-1870-01A | CD22 | chr19 | 35820133 | + | CADPS | chr3 | 62751659 | - |
ChimerDB4 | OV | TCGA-25-1870-01A | CD22 | chr19 | 35823827 | + | CADPS | chr3 | 62751659 | - |
ChimerDB4 | OV | TCGA-25-1870 | CD22 | chr19 | 35820133 | + | CADPS | chr3 | 62751659 | - |
ChimerDB4 | OV | TCGA-25-1870 | CD22 | chr19 | 35823827 | + | CADPS | chr3 | 62751659 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000419549 | CD22 | chr19 | 35823827 | + | ENST00000383710 | CADPS | chr3 | 62751659 | - | 5071 | 391 | 352 | 4011 | 1219 |
ENST00000419549 | CD22 | chr19 | 35823827 | + | ENST00000357948 | CADPS | chr3 | 62751659 | - | 4831 | 391 | 352 | 3774 | 1140 |
ENST00000419549 | CD22 | chr19 | 35823827 | + | ENST00000283269 | CADPS | chr3 | 62751659 | - | 4329 | 391 | 352 | 3894 | 1180 |
ENST00000419549 | CD22 | chr19 | 35823827 | + | ENST00000490353 | CADPS | chr3 | 62751659 | - | 2619 | 391 | 352 | 1323 | 323 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000419549 | ENST00000383710 | CD22 | chr19 | 35823827 | + | CADPS | chr3 | 62751659 | - | 0.000355786 | 0.99964416 |
ENST00000419549 | ENST00000357948 | CD22 | chr19 | 35823827 | + | CADPS | chr3 | 62751659 | - | 0.000510264 | 0.99948967 |
ENST00000419549 | ENST00000283269 | CD22 | chr19 | 35823827 | + | CADPS | chr3 | 62751659 | - | 0.000992522 | 0.9990075 |
ENST00000419549 | ENST00000490353 | CD22 | chr19 | 35823827 | + | CADPS | chr3 | 62751659 | - | 0.001239852 | 0.9987601 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >14412_14412_1_CD22-CADPS_CD22_chr19_35823827_ENST00000419549_CADPS_chr3_62751659_ENST00000283269_length(amino acids)=1180AA_BP=13 MRNGWNEYTSMSLISKQQLQTVKDRFQAFLNGETQIMADEAFMNAVQSYYEVFLKSDRVARMVQSGGCSANDSREVFKKHIEKRVRSLPE IDGLSKETVLSSWMAKFDAIYRGEEDPRKQQARMTASAASELILSKEQLYEMFQNILGIKKFEHQLLYNACQLDNPDEQAAQIRRELDGR LQMADQIARERKFPKFVSKEMENMYIEELKSSVNLLMANLESMPVSKGGEFKLQKLKRSHNASIIDMGEESENQLSKSDVVLSFSLEVVI MEVQGLKSLAPNRIVYCTMEVEGGEKLQTDQAEASKPTWGTQGDFSTTHALPAVKVKLFTESTGVLALEDKELGRVILHPTPNSPKQSEW HKMTVSKNCPDQDLKIKLAVRMDKPQNMKHSGYLWAIGKNVWKRWKKRFFVLVQVSQYTFAMCSYREKKAEPQELLQLDGYTVDYTDPQP GLEGGRAFFNAVKEGDTVIFASDDEQDRILWVQAMYRATGQSHKPVPPTQVQKLNAKGGNVPQLDAPISQFYADRAQKHGMDEFISSNPC NFDHASLFEMVQRLTLDHRLNDSYSCLGWFSPGQVFVLDEYCARNGVRGCHRHLCYLRDLLERAENGAMIDPTLLHYSFAFCASHVHGNR PDGIGTVTVEEKERFEEIKERLRVLLENQITHFRYCFPFGRPEGALKATLSLLERVLMKDIVTPVPQEEVKTVIRKCLEQAALVNYSRLS EYAKIEGKKREMYEHPVFCLASQVMDLTIQNVGRLITPAKKLEDTIRLAELVIEVLQQNEEHHAEAFAWWSDLMVEHAETFLSLFAVDMD AALEVQPPDTWDSFPLFQLLNDFLRTDYNLCNGKFHKHLQDLFAPLVVRYVDLMESSIAQSIHRGFERESWEPVNNGSGTSEDLFWKLDA LQTFIRDLHWPEEEFGKHLEQRLKLMASDMIESCVKRTRIAFEVKLQKTSRSTDFRVPQSICTMFNVMVDAKAQSTKLCSMEMGQEHQYH SKIDELIEETVKEMITLLVAKFVTILEGVLAKLSRYDEGTLFSSFLSFTVKAASKYVDVPKPGMDVADAYVTFVRHSQDVLRDKVNEEMY IERLFDQWYNSSMNVICTWLTDRMDLQLHIYQLKTLIRMVKKTYRDFRLQGVLDSTLNSKTYETIRNRLTVEEATASVSEGGGLQGISMK -------------------------------------------------------------- >14412_14412_2_CD22-CADPS_CD22_chr19_35823827_ENST00000419549_CADPS_chr3_62751659_ENST00000357948_length(amino acids)=1140AA_BP=13 MRNGWNEYTSMSLISKQQLQTVKDRFQAFLNGETQIMADEAFMNAVQSYYEVFLKSDRVARMVQSGGCSANDSREVFKKHIEKRVRSLPE IDGLSKETVLSSWMAKFDAIYRGEEDPRKQQARMTASAASELILSKEQLYEMFQNILGIKKFEHQLLYNACQLDNPDEQAAQIRRELDGR LQMADQIARERKFPKFVSKEMENMYIEELKSSVNLLMANLESMPVSKGGEFKLQKLKRSHNASIIDMGEESENQLSKSDVVLSFSLEVVI MEVQGLKSLAPNRIVYCTMEVEGGEKLQTDQAEASKPTWGTQGDFSTTHALPAVKVKLFTESTGVLALEDKELGRVILHPTPNSPKQSEW HKMTVSKNCPDQDLKIKLAVRMDKPQNMKHSGYLWAIGKNVWKRWKKRFFVLVQVSQYTFAMCSYREKKAEPQELLQLDGYTVDYTDPQP GLEGGRAFFNAVKEGDTVIFASDDEQDRILWVQAMYRATGQSHKPVPPTQVQKLNAKGGNVPQLDAPISQFYADRAQKHGMDEFISSNPC NFDHASLFEMGWFSPGQVFVLDEYCARNGVRGCHRHLCYLRDLLERAENGAMIDPTLLHYSFAFCASHVHGNRPDGIGTVTVEEKERFEE IKERLRVLLENQITHFRYCFPFGRPEGALKATLSLLERVLMKDIVTPVPQEEVKTVIRKCLEQAALVNYSRLSEYAKIEENVGRLITPAK KLEDTIRLAELVIEVLQQNEEHHAEAFAWWSDLMVEHAETFLSLFAVDMDAALEVQPPDTWDSFPLFQLLNDFLRTDYNLCNGKFHKHLQ DLFAPLVVRYVDLMESSIAQSIHRGFERESWEPVNNGSGTSEDLFWKLDALQTFIRDLHWPEEEFGKHLEQRLKLMASDMIESCVKRTRI AFEVKLQKTSRSTDFRVPQSICTMFNVMVDAKAQSTKLCSMEMGQEHQYHSKIDELIEETVKEMITLLVAKFVTILEGVLAKLSRYDEGT LFSSFLSFTVKAASKYVDVPKPGMDVADAYVTFVRHSQDVLRDKVNEEMYIERLFDQWYNSSMNVICTWLTDRMDLQLHIYQLKTLIRMV -------------------------------------------------------------- >14412_14412_3_CD22-CADPS_CD22_chr19_35823827_ENST00000419549_CADPS_chr3_62751659_ENST00000383710_length(amino acids)=1219AA_BP=13 MRNGWNEYTSMSLISKQQLQTVKDRFQAFLNGETQIMADEAFMNAVQSYYEVFLKSDRVARMVQSGGCSANDSREVFKKHIEKRVRSLPE IDGLSKETVLSSWMAKFDAIYRGEEDPRKQQARMTASAASELILSKEQLYEMFQNILGIKKFEHQLLYNACQLDNPDEQAAQIRRELDGR LQMADQIARERKFPKFVSKEMENMYIEELKSSVNLLMANLESMPVSKGGEFKLQKLKRSHNASIIDMGEESENQLSKSDVVLSFSLEVVI MEVQGLKSLAPNRIVYCTMEVEGGEKLQTDQAEASKPTWGTQGDFSTTHALPAVKVKLFTESTGVLALEDKELGRVILHPTPNSPKQSEW HKMTVSKNCPDQDLKIKLAVRMDKPQNMKHSGYLWAIGKNVWKRWKKRFFVLVQVSQYTFAMCSYREKKAEPQELLQLDGYTVDYTDPQP GLEGGRAFFNAVKEGDTVIFASDDEQDRILWVQAMYRATGQSHKPVPPTQVQKLNAKGGNVPQLDAPISQFYADRAQKHGMDEFISSNPC NFDHASLFEMVQRLTLDHRLNDSYSCLGWFSPGQVFVLDEYCARNGVRGCHRHLCYLRDLLERAENGAMIDPTLLHYSFAFCASHVHGNR PDGIGTVTVEEKERFEEIKERLRVLLENQITHFRYCFPFGRPEGALKATLSLLERVLMKDIVTPVPQEEVKTVIRKCLEQAALVNYSRLS EYAKIEENQKDAENVGRLITPAKKLEDTIRLAELVIEVLQQNEEHHAEPHVDKGEAFAWWSDLMVEHAETFLSLFAVDMDAALEVQPPDT WDSFPLFQLLNDFLRTDYNLCNGKFHKHLQDLFAPLVVRYVDLMESSIAQSIHRGFERESWEPVKSLTSNLPNVNLPNVNLPKVPNLPVN IPLGIPQMPTFSAPSWMAAIYDADNGSGTSEDLFWKLDALQTFIRDLHWPEEEFGKHLEQRLKLMASDMIESCVKRTRIAFEVKLQKTSR STDFRVPQSICTMFNVMVDAKAQSTKLCSMEMGQEHQYHSKIDELIEETVKEMITLLVAKFVTILEGVLAKLSRYDEGTLFSSFLSFTVK AASKYVDVPKPGMDVADAYVTFVRHSQDVLRDKVNEEMYIERLFDQWYNSSMNVICTWLTDRMDLQLHIYQLKTLIRMVKKTYRDFRLQG -------------------------------------------------------------- >14412_14412_4_CD22-CADPS_CD22_chr19_35823827_ENST00000419549_CADPS_chr3_62751659_ENST00000490353_length(amino acids)=323AA_BP=13 MRNGWNEYTSMSLISKQQLQTVKDRFQAFLNGETQIMADEAFMNAVQSYYEVFLKSDRVARMVQSGGCSANDSREVFKKHIEKRVRSLPE IDGLSKETVLSSWMAKFDAIYRGEEDPRKQQARMTASAASELILSKEQLYEMFQNILGIKKFEHQLLYNACQLDNPDEQAAQIRRELDGR LQMADQIARERKFPKFVSKEMENMYIEELKSSVNLLMANLESMPVSKGGEFKLQKLKRSHNASIIDMGEESENQLSKSDVVLSFSLEVVI -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:35820133/chr3:62751659) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CD22 | CADPS |
FUNCTION: Involved in intercellular adhesion, lymphocyte signaling, cytotoxicity and lymphokine secretion mediated by cytotoxic T-lymphocyte (CTL) and NK cell (PubMed:8673704). Cell surface receptor for NECTIN2. Upon ligand binding, stimulates T-cell proliferation and cytokine production, including that of IL2, IL5, IL10, IL13, and IFNG. Competes with PVRIG for NECTIN2-binding (PubMed:26755705). {ECO:0000269|PubMed:26755705, ECO:0000269|PubMed:8673704}. | FUNCTION: Calcium-binding protein involved in exocytosis of vesicles filled with neurotransmitters and neuropeptides. Probably acts upstream of fusion in the biogenesis or maintenance of mature secretory vesicles. Regulates neurotrophin release from granule cells leading to regulate cell differentiation and survival during cerebellar development. May specifically mediate the Ca(2+)-dependent exocytosis of large dense-core vesicles (DCVs) and other dense-core vesicles (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 20_138 | 137.33333333333334 | 848.0 | Domain | Note=Ig-like V-type |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 20_138 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like V-type |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 20_138 | 137.33333333333334 | 760.0 | Domain | Note=Ig-like V-type |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 20_138 | 137.33333333333334 | 867.0 | Domain | Note=Ig-like V-type |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 20_138 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like V-type |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000283269 | 0 | 28 | 380_495 | 147.0 | 1315.0 | Domain | C2 | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000283269 | 0 | 28 | 521_624 | 147.0 | 1315.0 | Domain | PH | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000283269 | 0 | 28 | 931_1111 | 147.0 | 1315.0 | Domain | MHD1 | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000357948 | 0 | 27 | 380_495 | 147.0 | 1275.0 | Domain | C2 | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000357948 | 0 | 27 | 521_624 | 147.0 | 1275.0 | Domain | PH | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000357948 | 0 | 27 | 931_1111 | 147.0 | 1275.0 | Domain | MHD1 | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000383710 | 0 | 30 | 380_495 | 147.0 | 1354.0 | Domain | C2 | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000383710 | 0 | 30 | 521_624 | 147.0 | 1354.0 | Domain | PH | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000383710 | 0 | 30 | 931_1111 | 147.0 | 1354.0 | Domain | MHD1 | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000490353 | 0 | 7 | 380_495 | 147.0 | 458.0 | Domain | C2 | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000490353 | 0 | 7 | 521_624 | 147.0 | 458.0 | Domain | PH | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000490353 | 0 | 7 | 931_1111 | 147.0 | 458.0 | Domain | MHD1 | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000283269 | 0 | 28 | 1177_1353 | 147.0 | 1315.0 | Region | Mediates targeting and association with DCVs | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000357948 | 0 | 27 | 1177_1353 | 147.0 | 1275.0 | Region | Mediates targeting and association with DCVs | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000383710 | 0 | 30 | 1177_1353 | 147.0 | 1354.0 | Region | Mediates targeting and association with DCVs | |
Tgene | CADPS | chr19:35823827 | chr3:62751659 | ENST00000490353 | 0 | 7 | 1177_1353 | 147.0 | 458.0 | Region | Mediates targeting and association with DCVs |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 143_235 | 137.33333333333334 | 848.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 242_326 | 137.33333333333334 | 848.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 331_416 | 137.33333333333334 | 848.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 419_500 | 137.33333333333334 | 848.0 | Domain | Note=Ig-like C2-type 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 505_582 | 137.33333333333334 | 848.0 | Domain | Note=Ig-like C2-type 5 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 593_676 | 137.33333333333334 | 848.0 | Domain | Note=Ig-like C2-type 6 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 143_235 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 242_326 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 331_416 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 419_500 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 505_582 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 5 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 593_676 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 6 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 143_235 | 137.33333333333334 | 760.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 242_326 | 137.33333333333334 | 760.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 331_416 | 137.33333333333334 | 760.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 419_500 | 137.33333333333334 | 760.0 | Domain | Note=Ig-like C2-type 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 505_582 | 137.33333333333334 | 760.0 | Domain | Note=Ig-like C2-type 5 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 593_676 | 137.33333333333334 | 760.0 | Domain | Note=Ig-like C2-type 6 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 143_235 | 137.33333333333334 | 867.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 242_326 | 137.33333333333334 | 867.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 331_416 | 137.33333333333334 | 867.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 419_500 | 137.33333333333334 | 867.0 | Domain | Note=Ig-like C2-type 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 505_582 | 137.33333333333334 | 867.0 | Domain | Note=Ig-like C2-type 5 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 593_676 | 137.33333333333334 | 867.0 | Domain | Note=Ig-like C2-type 6 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 143_235 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 242_326 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 331_416 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 419_500 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 505_582 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 5 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 593_676 | 137.33333333333334 | 671.0 | Domain | Note=Ig-like C2-type 6 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 760_765 | 137.33333333333334 | 848.0 | Motif | Note=ITIM motif 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 794_799 | 137.33333333333334 | 848.0 | Motif | Note=ITIM motif 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 820_825 | 137.33333333333334 | 848.0 | Motif | Note=ITIM motif 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 840_845 | 137.33333333333334 | 848.0 | Motif | Note=ITIM motif 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 760_765 | 137.33333333333334 | 671.0 | Motif | Note=ITIM motif 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 794_799 | 137.33333333333334 | 671.0 | Motif | Note=ITIM motif 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 820_825 | 137.33333333333334 | 671.0 | Motif | Note=ITIM motif 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 840_845 | 137.33333333333334 | 671.0 | Motif | Note=ITIM motif 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 760_765 | 137.33333333333334 | 760.0 | Motif | Note=ITIM motif 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 794_799 | 137.33333333333334 | 760.0 | Motif | Note=ITIM motif 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 820_825 | 137.33333333333334 | 760.0 | Motif | Note=ITIM motif 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 840_845 | 137.33333333333334 | 760.0 | Motif | Note=ITIM motif 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 760_765 | 137.33333333333334 | 867.0 | Motif | Note=ITIM motif 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 794_799 | 137.33333333333334 | 867.0 | Motif | Note=ITIM motif 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 820_825 | 137.33333333333334 | 867.0 | Motif | Note=ITIM motif 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 840_845 | 137.33333333333334 | 867.0 | Motif | Note=ITIM motif 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 760_765 | 137.33333333333334 | 671.0 | Motif | Note=ITIM motif 1 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 794_799 | 137.33333333333334 | 671.0 | Motif | Note=ITIM motif 2 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 820_825 | 137.33333333333334 | 671.0 | Motif | Note=ITIM motif 3 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 840_845 | 137.33333333333334 | 671.0 | Motif | Note=ITIM motif 4 |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 20_687 | 137.33333333333334 | 848.0 | Topological domain | Extracellular |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 707_847 | 137.33333333333334 | 848.0 | Topological domain | Cytoplasmic |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 20_687 | 137.33333333333334 | 671.0 | Topological domain | Extracellular |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 707_847 | 137.33333333333334 | 671.0 | Topological domain | Cytoplasmic |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 20_687 | 137.33333333333334 | 760.0 | Topological domain | Extracellular |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 707_847 | 137.33333333333334 | 760.0 | Topological domain | Cytoplasmic |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 20_687 | 137.33333333333334 | 867.0 | Topological domain | Extracellular |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 707_847 | 137.33333333333334 | 867.0 | Topological domain | Cytoplasmic |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 20_687 | 137.33333333333334 | 671.0 | Topological domain | Extracellular |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 707_847 | 137.33333333333334 | 671.0 | Topological domain | Cytoplasmic |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000085219 | + | 3 | 14 | 688_706 | 137.33333333333334 | 848.0 | Transmembrane | Helical |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000341773 | + | 3 | 12 | 688_706 | 137.33333333333334 | 671.0 | Transmembrane | Helical |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000536635 | + | 3 | 13 | 688_706 | 137.33333333333334 | 760.0 | Transmembrane | Helical |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000544992 | + | 3 | 13 | 688_706 | 137.33333333333334 | 867.0 | Transmembrane | Helical |
Hgene | CD22 | chr19:35823827 | chr3:62751659 | ENST00000594250 | + | 2 | 11 | 688_706 | 137.33333333333334 | 671.0 | Transmembrane | Helical |
Top |
Fusion Protein Structures |
PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file >>>1938_CD22_35823827_CADPS_62751659_ranked_0.pdb | CD22 | 35823827 | 35823827 | ENST00000490353 | CADPS | chr3 | 62751659 | - | MRNGWNEYTSMSLISKQQLQTVKDRFQAFLNGETQIMADEAFMNAVQSYYEVFLKSDRVARMVQSGGCSANDSREVFKKHIEKRVRSLPE IDGLSKETVLSSWMAKFDAIYRGEEDPRKQQARMTASAASELILSKEQLYEMFQNILGIKKFEHQLLYNACQLDNPDEQAAQIRRELDGR LQMADQIARERKFPKFVSKEMENMYIEELKSSVNLLMANLESMPVSKGGEFKLQKLKRSHNASIIDMGEESENQLSKSDVVLSFSLEVVI MEVQGLKSLAPNRIVYCTMEVEGGEKLQTDQAEASKPTWGTQGDFSTTHALPAVKVKLFTESTGVLALEDKELGRVILHPTPNSPKQSEW HKMTVSKNCPDQDLKIKLAVRMDKPQNMKHSGYLWAIGKNVWKRWKKRFFVLVQVSQYTFAMCSYREKKAEPQELLQLDGYTVDYTDPQP GLEGGRAFFNAVKEGDTVIFASDDEQDRILWVQAMYRATGQSHKPVPPTQVQKLNAKGGNVPQLDAPISQFYADRAQKHGMDEFISSNPC NFDHASLFEMVQRLTLDHRLNDSYSCLGWFSPGQVFVLDEYCARNGVRGCHRHLCYLRDLLERAENGAMIDPTLLHYSFAFCASHVHGNR PDGIGTVTVEEKERFEEIKERLRVLLENQITHFRYCFPFGRPEGALKATLSLLERVLMKDIVTPVPQEEVKTVIRKCLEQAALVNYSRLS EYAKIEENQKDAENVGRLITPAKKLEDTIRLAELVIEVLQQNEEHHAEPHVDKGEAFAWWSDLMVEHAETFLSLFAVDMDAALEVQPPDT WDSFPLFQLLNDFLRTDYNLCNGKFHKHLQDLFAPLVVRYVDLMESSIAQSIHRGFERESWEPVKSLTSNLPNVNLPNVNLPKVPNLPVN IPLGIPQMPTFSAPSWMAAIYDADNGSGTSEDLFWKLDALQTFIRDLHWPEEEFGKHLEQRLKLMASDMIESCVKRTRIAFEVKLQKTSR STDFRVPQSICTMFNVMVDAKAQSTKLCSMEMGQEHQYHSKIDELIEETVKEMITLLVAKFVTILEGVLAKLSRYDEGTLFSSFLSFTVK AASKYVDVPKPGMDVADAYVTFVRHSQDVLRDKVNEEMYIERLFDQWYNSSMNVICTWLTDRMDLQLHIYQLKTLIRMVKKTYRDFRLQG | 1219 |
Top |
pLDDT score distribution |
pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
CD22_pLDDT.png |
CADPS_pLDDT.png |
pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
Top |
Ramachandran Plot of Fusion Protein Structure |
Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
CD22 | |
CADPS |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to CD22-CADPS |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to CD22-CADPS |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |